CJC-1295 No DAC + Ipamorelin 10MG
$90.00
CJC-1295 No DAC + Ipamorelin 10MG is a combined 10MG format pairing a CJC 1295 (no DAC) GHRH analogue with ipamorelin, a ghrelin receptor agonist peptide. This blend is commonly used in research that examines pulsatile growth hormone signaling pathways and IGF 1 related biomarkers. Studies have explored these peptides in endocrine and metabolism focused experimental models.
In Stock
- Delivery & Return
Delivery
We ship to all address in Canada and all 50 states, Washington DC. All orders are shipped with a Canada Post tracking number. Always free shipping for orders over $500. During sale periods and promotions the delivery time may be longer than normal. Items marked "On-Demand" "Special Order" "On Backorder" are not refundable or eligible for return as they are ordered on a case by case basis.Return
Due to the nature of the products we sell, and for health safety concerns for our valuable customers, our products are non-returnable (sales are final). This policy will be strictly enforced.Help
Give us a shout if you have any other questions and/or concerns. Email:Â sales@mecp.ca Phone: +1 (437) 990-9174 - Ask a Question
CJC-1295 No DAC + Ipamorelin 10MG is a combined 10MG format of two synthetic peptides frequently used together in laboratory research. CJC 1295 no DAC is a growth hormone releasing hormone analogue designed without a drug affinity complex, while ipamorelin is a selective ghrelin receptor agonist peptide.
Researchers study CJC-1295 No DAC + Ipamorelin 10MG in the context of growth hormone pulse dynamics, downstream signaling, and circulating biomarker measurement in controlled experimental settings. Preclinical and translational studies have examined these peptide classes in models related to endocrine regulation, metabolism, and recovery oriented research questions, with outcomes dependent on study design and assays used.
- Specification: 10MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
MOTS-C 10MG is a 10-milligram format of MOTS-C, a 16 amino acid mitochondria-derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-C in relation to metabolic signaling, cellular stress responses, and mitochondrial nuclear communication in preclinical systems. Its small size and endogenous origin make it a common target in mechanistic peptide research.
In Stock
Glutathione – 600MG is a 600-milligram format of glutathione, a naturally occurring tripeptide made from glutamate, cysteine, and glycine. Researchers study glutathione in redox biology and oxidative stress models, including work focused on cellular antioxidant systems. It is also used in laboratory assays that examine thiol status and detoxification related pathways.
In Stock
SNAP-8 – 10MG is a 10-milligram format of SNAP-8, a synthetic octapeptide commonly referred to as acetyl octapeptide 3. It is studied in cosmetic science as a topical model peptide related to SNAP-25 SNARE pathway research. Researchers have examined SNAP-8 in the context of peptide signalling and skin surface appearance studies.
In Stock
NAD 100MG is a 100-milligram format of nicotinamide adenine dinucleotide (NAD+), a ubiquitous pyridine nucleotide that participates in cellular redox reactions. Researchers study NAD+ in the context of mitochondrial metabolism, oxidative stress models, and enzyme systems such as sirtuins and PARPs.
In Stock
CJC 1295 Without DAC 10MG | GHRH 1 29 Peptide Analogue is a 10 mg format of the short GHRH 1 to 29 analogue commonly referred to as Mod GRF 1 to 29. Researchers study this peptide in laboratory work focused on growth hormone signaling models and pulsatile release dynamics. It is frequently used as a reference compound in peptide endocrinology research.
In Stock
MT1 10Mg 10MG refers to a 10-milligram format of MT1, a melanocortin research peptide commonly associated with melanotropin analog research. Researchers study MT1 in the context of melanocortin receptor signaling, pigmentation pathways, and related neuroendocrine models.
In Stock
SS-31 50MG is a 50-milligram format of SS-31, a synthetic tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential to localize to mitochondria and for its use in preclinical models examining mitochondrial membrane and bioenergetic pathways.
In Stock
NAD 1000MG is a 1000-milligram format of nicotinamide adenine dinucleotide, a ubiquitous pyridine nucleotide cofactor central to cellular redox chemistry. Researchers study NAD in relation to mitochondrial metabolism, energy transfer reactions, and NAD dependent signaling pathways.
In Stock
GHK-Cu + TB-500 + BPC-157 + KPV 80MG is an 80-milligram multi-peptide blend combining a copper tripeptide complex with three commonly studied synthetic peptides. Researchers investigate these components in preclinical and in vitro work related to extracellular matrix biology, cell migration signaling, and tissue model recovery. Studies have also examined GHK-Cu, TB-500, BPC-157, and KPV in contexts involving inflammatory signaling pathways and barrier integrity models.
In Stock
NAD 500MH refers to a 500MH format of nicotinamide adenine dinucleotide (NAD), a ubiquitous pyridine dinucleotide central to cellular redox chemistry. Researchers study NAD in work involving energy metabolism, mitochondrial function, and enzymatic pathways such as sirtuins and PARPs.
In Stock
CJC 1295 With DAC 5MG is a 5-milligram format of CJC-1295 with drug affinity complex (DAC), a synthetic growth hormone releasing hormone analogue peptide. Researchers study this modified GHRH fragment for its potential to extend peptide half life through albumin binding. Studies have examined CJC 1295 With DAC 5MG in preclinical and investigational settings focused on pulsatile GH signaling and IGF 1 related endpoints.
In Stock
Estradiol Cypionate 10mg/ml, 10ml is a specified concentration and volume format of estradiol cypionate, an esterified form of 17 beta estradiol. Researchers use estradiol esters in laboratory work where sustained release profiles are examined in analytical, receptor binding, and pharmacokinetic models.
In Stock


